Related Experiment Video
Updated: Aug 14, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human papillomavirus and cervical cancer
1Henry Ford Hospital, Detroit, Michigan 48202, USA. eburd1@hfhs.org
Clinical Microbiology Reviews
|January 15, 2003
Summary
Human papillomavirus (HPV) testing aids in detecting cervical precancerous lesions. Identifying high-risk HPV types improves diagnostic accuracy and guides patient management, potentially preventing cervical cancer progression.
Area of Science:
- Gynecology
- Oncology
- Virology
Background:
- Human papillomavirus (HPV) is linked to cervical cancer.
- Cervical cancer development involves HPV and cofactors.
- Early detection of precancerous lesions is crucial for prevention.
Purpose of the Study:
- To evaluate the role of HPV DNA testing as an adjunct to cytology for cervical cancer screening.
- To assess the utility of HPV testing in improving diagnostic accuracy for borderline or mildly abnormal cytologic results.
Main Methods:
- Review of existing literature on HPV infection and cervical cancer.
- Analysis of the performance of HPV DNA testing compared to cytologic screening.
- Evaluation of HPV testing's ability to differentiate high-risk from low-risk HPV types.
Main Results:
- HPV is essential but not sufficient for cervical cancer development.
- Cytologic screening can miss or misclassify cervical abnormalities.
- HPV DNA testing demonstrates sensitivity and specificity in detecting high-risk HPV types.
- HPV testing improves diagnostic accuracy, especially for borderline cytologic results.
Conclusions:
- HPV DNA testing is a valuable adjunct to cytology for cervical cancer screening.
- Early detection of high-risk HPV types can enhance patient triage and treatment decisions.
- HPV testing helps limit unnecessary colposcopy in specific patient groups.
Related Concept Videos
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...